BIOMAT Database Logo BIOMAT Database Logo

Mixing short and intermediate acting insulins in the syringe: effect on postprandial blood glucose concentrations in type I diabetics. 1985

R J Heine, and H J Bilo, and A C Sikkenk, and E A van der Veen

UI MeSH Term Description Entries
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007336 Insulin, Isophane An intermediate-acting INSULIN preparation with onset time of 2 hours and duration of 24 hours. It is produced by crystallizing ZINC-insulin-PROTAMINES at neutral pH 7. Thus it is called neutral protamine Hagedorn for inventor Hans Christian Hagedorn. Insulin, NPH,Insulin, Protamine Zinc,Isophane Insulin, Regular,NPH Insulin,Neutral Protamine Hagedorn Insulin,Protamine Hagedorn Insulin,Hagedorn Insulin, Protamine,Isophane Insulin,Protamine Zinc Insulin,Regular Isophane Insulin,Zinc Insulin, Protamine
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D049528 Insulin, Long-Acting Insulin formulations that contain substances that retard absorption thus extending the time period of action. Insulin, Semilente,Long-Acting Insulin,Insulin, Long Acting,Long Acting Insulin,Semilente Insulin

Related Publications

R J Heine, and H J Bilo, and A C Sikkenk, and E A van der Veen
Mixing short and intermediate acting insulins: effect on postprandial blood glucose concentrations.
March 1985, British medical journal (Clinical research ed.),
R J Heine, and H J Bilo, and A C Sikkenk, and E A van der Veen
Mixing short and intermediate acting insulins: effect on postprandial blood glucose concentrations.
May 1985, British medical journal (Clinical research ed.),
R J Heine, and H J Bilo, and A C Sikkenk, and E A van der Veen
Effects of mixing short- and intermediate-acting insulins on absorption course and biologic effect of short-acting preparation.
January 1986, Diabetes care,
R J Heine, and H J Bilo, and A C Sikkenk, and E A van der Veen
Miscibility of short- and intermediate-acting insulins.
January 1985, The Netherlands journal of medicine,
R J Heine, and H J Bilo, and A C Sikkenk, and E A van der Veen
The effect of mixing regular- and intermediate-acting insulins on their absorption and biological activity.
March 1988, Experimental and clinical endocrinology,
R J Heine, and H J Bilo, and A C Sikkenk, and E A van der Veen
The effect of insulin mixtures in type I diabetics: influence of the intermediate acting insulin on the action of short acting insulin.
January 1987, Diabete & metabolisme,
R J Heine, and H J Bilo, and A C Sikkenk, and E A van der Veen
Pharmacokinetics and glucodynamics of rapid-, short-, and intermediate-acting insulins: comparison of jet injection to needle syringe.
January 2002, Diabetes technology & therapeutics,
R J Heine, and H J Bilo, and A C Sikkenk, and E A van der Veen
The clinical effects of mixing short- and intermediate-acting insulins in the treatment of non-insulin-dependent diabetes.
June 1987, The Medical journal of Australia,
R J Heine, and H J Bilo, and A C Sikkenk, and E A van der Veen
Outpatient use of intermediate- and short-acting semisynthetic human insulins.
March 1983, Archives of internal medicine,
R J Heine, and H J Bilo, and A C Sikkenk, and E A van der Veen
Intermediate acting insulin given at bedtime: effect on blood glucose concentrations before and after breakfast.
April 1983, British medical journal (Clinical research ed.),
Copied contents to your clipboard!